Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SCTX Scribe Therapeutics Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $17.18 -6.7% | $15.90 -2.5% |
| StockIQ Score | 39F Weak Risk: High | 41D Weak Risk: High |
| Technical | 24F | 36F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 74B | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Scribe Therapeutics (SCTX) has a slightly lower investor score (39 vs. 41) and weaker technical score (24 vs. 36) compared to Ascentage Pharma (AAPG). AAPG stands out with available growth and valuation scores (50 and 38), while SCTX lacks these metrics entirely, making AAPG appear stronger in measurable areas. Both share the same "WEAK" rating.
